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Abstract Ageing is assumed to be accompanied by greater
health care expenditures but the association is also viewed
as a ‘red herring’. This study aimed to evaluate whether
age is associated with health care costs in the senior
elderly, using electronic health records for 98,220 partici-
pants aged 80 years and over registered with the UK
Clinical Practice Research Datalink and linked Hospital
Episode Statistics (2010–2014). Annual costs of health
care utilization were estimated from a two-part model;
multiple fractional polynomial models were employed to
evaluate the non-linear association of age with predicted
health care costs while also controlling for comorbidities,
impairments, and death proximity. Annual health care
costs increased from 80 years (£2972 in men, £2603 in
women) to 97 (men; £4721) or 98 years (women; £3963),
before declining. Costs were significantly elevated in the
last year of life but this effect declined with age, from
£10,027 in younger octogenarians to £7021 in centenarians.
This decline was steeper in participants with comorbidities
or impairments; £14,500 for 80–84-year-olds and £6752
for centenarians with 7? impairments. At other times,
comorbidity and impairments, not age, were main drivers
of costs. We conclude that comorbidities, impairments, and
proximity to death are key mediators of age-related
increases in health care costs. While the costs of comor-
bidity among survivors are not generally associated with
age, additional costs in the last year of life decline with
age.
Keywords Health care costs  Electronic health records 
Elderly  Ageing  Ecological fallacy
JEL Classification H41  H51  I10  I18
Introduction
The senior elderly, aged 80 years and older, represent the
fastest-growing age group in the majority of the developed
world [19, 23] with the number of centenarians in the
United Kingdom (UK) increasing by 65% over the past
decade [24]. While increases in life expectancy and con-
sequent rapid increases in the older age population are
considered positive developments, the consequential future
health care burden represents a leading concern for health
services. Most commentaries incorporate an assumption
that greater longevity and associated illness burden will be
associated with substantial increases in health care costs.
A high proportion of lifetime health care costs incur
towards the end of life [1, 9, 39], being associated with the
management of terminal illness [12, 27] and the type of
care received at the end of life [30]. This balance of costs
across the life-course contributes to a potentially exagger-
ated assumption that increasing age itself is necessarily a
driver of increased costs. The Organisation for Economic
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Co-Operation and Development’s (OECD) report on public
spending in health and long-term care found that demo-
graphic change did not account for recent growth in public
health care expenditures [25]. Between 1995 and 2009,
public health spending grew by 4.3% per year on average
in OECD countries, of which only 0.5% might be
attributable to demographic developments [25].
Zweifel et al. [39] suggested that the proposed associ-
ation of age with health care costs is a ‘red herring’. In their
analyses, health care expenditures depended on remaining
lifetime, and proximity to death, rather than calendar age
[39]. Subsequent reports from the same authors and others
have addressed methodological critiques [29] and con-
firmed the initial interpretation [13, 31, 35, 40]. However,
while Zweifel et al. proposed that age is a ‘red herring’,
Howdon and Rice [13] suggest that time to death is itself a
‘red herring’ that acts as a proxy for morbidity [13].
There is still presently insufficient evidence to support
the ‘red herring’ claim in the senior elderly aged 80 years
and older. Previous studies evaluating health care costs in
the elderly evaluate younger elderly populations
[5, 8, 14, 15, 18, 33] and few present data disaggregated by
age category. In the senior elderly, age-related impairments
(e.g., cognitive impairment, falls, fractures) become
increasingly important, alongside multiple comorbidities
[e.g., cancer, stroke, diabetes mellitus (DM)], but few
studies have analyzed coded data for both impairments and
morbidities [10]. Data for population sub-groups above
80 years are not widely reported and have not been ana-
lyzed separately in larger population-based samples. In
smaller cohort studies, health care utilization and costs
overall have been shown to increase with age, but some
studies suggest that costs of medications, specialist visits,
and surgical admissions may not increase beyond the age
of 85 years [5, 34]. In the United States (US), Medicare
spending between 2000 and 2001 increased with age until
the mid-90s with spending decreasing in senior elderly
years (95?) [21]. Another Medicare study reported average
per-capita total health care expenditures in 2014 reaching a
maximum at 97 years of age and per-capita spending being
highest for those in their early 70s compared to older
groups, mainly due to inpatient hospital-related spending
[2]. Age has also previously been shown to have little
predictive power on health care costs when controlling for
life expectancy in the US, and the predictive power of life
expectancy diminishes as health status variables are intro-
duced [32]. Equivalent data have not been reported in large
population-based cohorts of senior elderly in the UK.
The present study aimed to test the ‘red herring’
hypothesis in the senior elderly population. The study
addresses an empirical gap in the literature concerning the
trajectory of health care costs in the over-80s. We use
primary care electronic health records (EHRs), with linked
data for hospital utilization and drug prescribing, to ana-
lyze multiple age-related impairments, in addition to
comorbidities, and to associate these with health care uti-
lization and costs. We employed multivariable fractional
polynomial models to estimate potential non-linearity in
the association of age with health care costs, hypothesizing
that in the senior elderly, aged 80 years and older, the
independent effect of increasing age is not the main driver
of health care costs, but rather the number of comorbidities,
impairments, and proximity to death are.
Methods
Data source
Data were obtained from the Clinical Practice Research
Datalink (CPRD), a nationally representative primary care
database of EHRs in the UK containing anonymized
patient records for approximately 7% of the UK population
[11, 17]. Patients included in the database are broadly
representative of the UK population [17] and EHR data
including clinical diagnoses, consultations by type, and
drug prescriptions have been shown to be valid in many
studies [36]. The CPRD referral files also contain coded
information from primary care EHRs concerning referrals
to hospital and hospital discharge letters. The present study
was restricted to general practices in England that partici-
pated in data linkage (372 practices in our sample) with
secondary care data. Linked hospital utilization data were
obtained from the Hospital Episode Statistics (HES) data-
set [22] up to February 2016, providing information on
hospital admissions. This study was approved through a
protocol submitted to the Medicines and Health care
Products Regulatory Agency (MHRA) Independent Sci-
entific Advisory Committee (ISAC) for CPRD studies
(Protocol No. 15_047).
Sample
This research was part of a wider study on ageing. An age-
stratified random sample was selected from the list of all
patients registered at CPRD general practices. The sample
was stratified by those who had their 80th, 85th, 90th, 95th,
and 100th birthdays while registered with CPRD to provide
over-representation of older age groups. The present
analysis was restricted to those CPRD general practices in
England that participated in HES data linkage in the most
recent 5-year period, 2010–2014. The final sample com-
prised 98,220 participants aged 80 years and older, with
linked HES records, and eligible person-time between 2010
and 2014.
N. C. Hazra et al.
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Costing analysis
Person-time at risk was calculated for each participant by
year from 2010 to 2014. Person-time was further subdivided
into time in the last 12 months of life (decedents) and all
other time (survivors). Eligible person-time was also strat-
ified by 5-year age group, gender, comorbidity category, and
impairment category using the first record for each condi-
tion, as reported previously [10]. Comorbidities included:
coronary heart disease (CHD), stroke, cancer, DM, hyper-
tensive diseases, chronic respiratory diseases, muscu-
loskeletal diseases, digestive diseases, and nervous system
disorders. Age-related impairments included: cognitive
decline and memory problems, dementia, depression, con-
fusion and delirium, falls, fractures, hearing impairment,
incontinence, mobility and gait problems, visual impair-
ment, and musculoskeletal pain. For analysis, comorbidities
and age-related impairments were grouped into the cate-
gories: none; one to three; four to six; and seven or more.
The bottom-up costing approach was implemented by
identifying and enumerating all types of resources used and
assigning a unit cost to each resource. Primary care con-
tacts were enumerated from EHRs, including general
practice (GP) consultations, emergency consultations,
telephone consultations, home visits, and out-of-hours
consultations. Data for all drug prescriptions issued in
primary care were also analyzed. Hospital utilization,
including inpatient hospital admissions, outpatient visits,
day case visits, and accident and emergency (A&E) visits,
were enumerated from referral records with linked HES
data for inpatient admissions. Unit costs of health care
utilization were obtained from standard reference sources
including the Personal Social Services Research Unit
(PSSRU) Costs of Health and Social Care 2015 report [26]
for primary care utilization and the NHS reference costs [3]
(Supplementary Table 1) for secondary care utilization.
The total number of drugs prescribed from 2010 to 2014
were enumerated in CPRD and unit prescription costs were
obtained by linking the Gemscript drug code for each
prescription to item-specific costs from the RESIP Gem-
script Code Dictionary (RESIP UK, Chertsey, Surrey, UK).
All utilization analyses and costing of prescriptions were
conducted using Stata Version 14.0.
Two-part model
We modeled the association of annual health care costs
with age group, gender, comorbidity category, impairment
category, and proximity to death as well as interactions
between these variables and costs. Proximity to death was
represented using a dummy variable for person-time in the
12 months before death. A two-stage regression model was
employed [4, 16]:
E Y jXð Þ ¼ P Y[ 0jXð Þ  EðYjX; Y[ 0Þ;
where P is the probability of non-zero costs; E the expected
value of; Y the cost of health care utilization per participant
year; and X represents covariates of interest.
A probit model was employed to predict the probability
of costs being incurred [6] allowing for the proportion of
participants not utilizing services, which with an elderly
population is low but still existent. A general linear model
(GLM) [20] with log-link and gamma errors was employed
to model health care expenditures, conditional on health
care being utilized. The model incorporated the main
effects of gender, dying (costs in last 12 months of life),
comorbidity category and impairment category, as well as
age and 5-year age group. Age was included as a cate-
gorical variable to allow for non-linearity of association
[1]. We also included age as a continuous variable to
account for differences in the distribution of age within age
groups. All potential interaction terms were evaluated
stepwise by comparing goodness-of-fit with or without the
term. Due to the panel structure of the data, robust variance
estimates were employed to account for correlation clus-
tering of repeated observations on individual participants.
The predicted costs of health care utilization were then
estimated as the product of the predicted probabilities of
health care being utilized and the predicted costs of
utilization.
In order to further evaluate the association of age with
model-predicted costs of health care utilization, we
employed second-order fractional polynomial (FP) models
[28]. The fractional polynomial approach systematically
evaluates non-linearity by finding the best-fitting power
transformation xp, with p chosen from -2, -1, -0.5, 0,
0.5, 1, 2, 3, where x0 represents log x. Second-order models
take the form:
y ¼ b0þb1xp þ b2xq;
where q is selected in the same manner as p. Models were
fitted with age as a predictor of costs for sub-groups of
gender, death (last 12 months of life) and comorbidity and
impairment category. Models were fitted using the ‘mfp’
command in Stata version 14.0, with predicted values
estimated using the ‘fracpred’ command. We did not
incorporate FPs directly into the two-part model because
the FP approach does not readily accommodate interaction
terms.
Results
There were 98,220 participants (54,014, 55%, women)
contributing a total of 300,672 years of person-time to the
analysis (Table 1). The proportion of person-time
Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or…
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contributed by women increased from 49% at 80–84 years
to 81% in centenarians. The age distribution of person-time
was 31% at 80–84 years, 36% at 85–89 years, 24% at
90–94 years, 8% at 95–99 years and 1% for centenarians
(Table 1). The proportion of person-time for decedents in
the last 12 months of life was 4% at 80–84 years increas-
ing to 24% in centenarians. The proportion of person-time
associated with four or more comorbidities was 58% at
80–84 years but decreased from 95 years and above, while
the proportion associated with four or more age-related
impairments increased from 15% at 80–84 years to 31% in
centenarians.
The annual rate of home visits and out-of-hours con-
sultations increased with age, but GP consultations and
outpatient utilization declined significantly with age after
90 years and hospital inpatient utilization declined beyond
95 years of age (Table 2). Telephone consultations
increased with age, declining after 99 years with lower
annual utilization and cost rates among centenarians. The
cost of all primary care services increased significantly
with age from 80 up to approximately 95 or 99 years,
before declining in the oldest age group, while secondary
care service costs increased significantly from 80 to
90 years, reaching a plateau in nonagenarians and declin-
ing beyond 99 years; primary care costs peaked at
95–99 years (£676 per person year) and secondary care
costs at 90–94 years (£2737 per person year). Annual
prescription costs similarly increased with age from £578
per person year at 80–84 years to £712 at 90–94 years,
with the lowest rate of prescription costs among cente-
narians (£526 per person year). The percent distribution
across type of health care spending remained relatively
constant across age groups; with primary care accounting
for approximately 16% of cost, secondary care for 68% and
prescriptions for 16% (Table 2).
The two-part regression model estimating predicted
costs based on the cohort’s health service utilization is
presented in Table 3. Higher coefficients associated with a
covariate indicate a greater probability of utilizing health
care in the probit model, or greater health care costs in the
GLM. Women were more likely than men to use health
care or to incur positive costs, as suggested in the probit
model (coeff. 0.29, 95% CI 0.19–0.39, p\ 0.001)
(Table 3), but among those using health care, there was no
significant difference in spending between men and women
including all interaction terms (-0.12, -0.35 to 0.11,
p = 0.289). The probability of using health care did not
change with age, except for over-100s displaying a sig-
nificantly lower probability of incurring costs compared to
80–84-year-olds (-0.94, -1.23 to -0.64, p\ 0.001).
Among those using health care, costs remained similar in
all age-groups with non-significant coefficients in the
GLM. With increasing comorbidity and impairment cate-
gory, the probability of incurring positive costs increased in
the probit model (2.27, 2.08–2.46, p\ 0.001 for 7–9
comorbidities compared to none), as did the estimated costs
among users of health care in the GLM (1.34, 1.10–1.58,
p\ 0.001 for 7–9 comorbidities compared to none). The
proportion with comorbidities and age-related impairments
are presented by age in Fig. 1. Proximity to death proved to
be the strongest driver of high cost with the probability of
using health care (0.79, 0.65–0.93, p\ 0.001) and the cost
of health care (1.46, 1.24–1.68, p\ 0.001) being signifi-
cantly higher in the last 12 months of life. The additional
costs associated with dying declined substantially with age.
There was a quantitatively important age-group interaction
Table 1 Characteristics of
sample
80–84 85–89 90–94 95–99 100? p valuea
Person years 93,317 107,394 72,476 22,943 4542
Female 45,439 (49) 55,922 (52) 43,528 (60) 17,567 (77) 3688 (81) \0.001
Last year of life 3668 (4) 7883 (7) 9215 (13) 4686 (20) 1087 (24) \0.001
Number of comorbidities
0 1945 (2) 2168 (2) 1561 (2) 784 (3) 484 (11) \0.001
1–3 36,842 (39) 39,344 (37) 26,679 (37) 9677 (42) 2132 (47) 0.003
4–6 51,591 (55) 62,138 (58) 42,018 (58) 11,981 (53) 1857 (41) \0.001
7? 2939 (3) 3744 (3) 2218 (3) 500 (2) 69 (1) \0.001
Number of impairments
0 15,266 (16) 13,879 (13) 7513 (10) 2154 (9) 736 (16) \0.001
1–3 64,405 (69) 70,766 (66) 44,722 (62) 13,070 (57) 2394 (53) \0.001
4–6 12,944 (14) 21,151 (20) 18,452 (25) 6943 (30) 1275 (28) \0.001
7? 702 (1) 1598 (1) 1788 (3) 775 (3) 137 (3) \0.001
Figures are frequencies (column percents)
a Test for trend across age groups
N. C. Hazra et al.
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with proximity to death. This interaction term indicates that
the probability of incurring health care costs increased with
age among decedents, and provides justification for sub-
group level presentation of costs. While there were sig-
nificant increases in the probability of decedents using
health care for each successive age-group (0.19, 0.11–0.26,
p\ 0.001 at 85–89 years; 1.74, 1.58–1.90, p\ 0.001 at
100? years), estimated costs among decedents using care
declined with age-group, as shown in the GLM (-0.38,
-0.55 to -0.20, p\ 0.001 at 100? years compared to
80–84 years).
Table 4 outlines mean annual predicted costs of health
care utilization by age subgroups of gender, proximity to
death, comorbidity category and impairment category.
Overall, annual costs of health care utilization increased
from £3095 at 80–84 years to £4322 at 95–99 years,
declining to £3698 among centenarians. A marginal
increase in cost is observed with increasing age from 80
years in all sub-groups, followed by lower and declining
costs in the later nonagenarian years up to 100 years and
older. Costs among decedents in the 12 months before
death were considerably higher compared to other years.
For decedents in the last 12 months of life, mean annual
predicted costs declined from £10,027 at 80–84 years to
£7021 in centenarians, while remaining relatively constant
with age among survivors, ranging from £2000 to £3000. In
all age groups, costs increased with a greater number of
comorbidities and impairments, with the largest increases
Table 2 Age-stratified utilization, prescriptions, and costs by age-group and person-time, 2010–2014
80–84 years 85–89 years 90–94 years 95–99 years 100? years
93,317 107,394 72,476 22,943 4542
General practice consultations
Rate per person year 11.13 11.66 11.28 10.10 7.34
Cost per person year £500.96 £524.83 £507.65 £454.52 £330.49
Telephone consultations
Rate per person year 0.97 1.20 1.40 1.42 1.04
Cost per person year £26.11 £32.29 £37.59 £38.29 £28.30
Home visits
Rate per person year 0.40 0.77 1.34 2.03 2.02
Cost per person year £35.73 £68.00 £118.92 £180.49 £179.33
Out-of-hours
Rate per person year 0.02 0.03 0.04 0.05 0.05
Cost per person year £0.84 £1.24 £1.56 £2.27 £2.18
Primary care cost (% total) £563.64 (16%) £626.37 (16%) £665.71 (16%) £675.57 (17%) £540.02 (19%)
Prescriptions
Rate per person year 68.2 80.1 88.8 86.7 63.9
Pres. cost (% total) £577.77 (16%) £657.45 (16%) £712.74 (17%) £690.46 (18%) £525.60 (18%)
Inpatient episodes
Rate per person year 0.81 0.91 0.91 0.86 0.61
Cost per person year £2206.14 £2479.75 £2495.86 £2352.18 £1672.39
Outpatient visits
Rate per person year 0.85 0.90 0.86 0.76 0.46
Cost per person year £234.13 £248.57 £235.52 £207.59 £126.61
Day case episodes
Rate per person year 0.01 0.01 0.004 0.002 0.001
Cost per person year £3.99 £3.58 £2.80 £1.6 £0.48
Emergency visits
Rate per person year 0.02 0.02 0.02 0.02 0.017
Cost per person year £1.99 £2.42 £2.67 £3.08 £2.24
Secondary care cost (% total) £2446.26 (68%) £2734.32 (68%) £2736.84 (67%) £2564.48 (65%) £1801.70 (63%)
Total cost £3587.66 £4018.14 £4115.29 £3930.51 £2867.33
Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or…
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among younger age-group decedents in the 12 months
before death.
The association of age with health care costs was further
investigated in fractional polynomial (FP) models. In order
to present the previously demonstrated significant
interaction effects, FP models were fitted separately for
sub-groups of gender, death and category of comorbidity,
and age-related impairment. FP terms selected for age in
each sub-group are presented in Table 5. First- and second-
order terms selected for analysis of person-time among
Table 3 Two-part regression model for health care costs
Predictor Probit model GLM model
Coefficient (95% confidence interval) p value Coefficient (95% confidence interval) p value
Age
Single year -0.04 (-0.05 to -0.04) \0.001 0.001 (-0.003 to 0.006) 0.543
Gender
Female 0.29 (0.19–0.39) \0.001 -0.12 (-0.35 to 0.11) 0.289
Age group (years)
80–84 Ref. Ref.
85–89 0.09 (-0.01 to 0.19) 0.089 0.35 (0.05–0.65) 0.024
90–94 0.04 (-0.09 to 0.17) 0.515 0.42 (0.18–0.67) 0.001
95–99 -0.09 (-0.27 to 0.09) 0.320 0.31 (0.02–0.60) 0.039
100? -0.94 (-1.23 to -0.64) \0.001 0.40 (-0.20 to 1.01) 0.192
Proximity to death
Year before death (YD) 0.79 (0.65–0.93) \0.001 1.46 (1.24–1.68) \0.001
Age group 9 year before death (YD) interaction
80–84.YD Ref. Ref.
85–89.YD 0.19 (0.11–0.26) \0.001 -0.10 (-0.18 to -0.02) 0.012
90–94.YD 0.40 (0.32–0.47) \0.001 -0.23 (-0.31 to -0.16) \0.001
95–99.YD 0.75 (0.66–0.85) \0.001 -0.29 (-0.38 to -0.20) \0.001
100? .YD 1.74 (1.58–1.90) \0.001 -0.38 (-0.55 to -0.20) \0.001
Comorbidity category
0 Ref. Ref.
1–3 1.55 (1.46–1.65) \0.001 0.48 (0.25–0.71) \0.001
4–6 2.25 (2.15–2.35) \0.001 0.93 (0.70–1.16) \0.001
7–9 2.27 (2.08–2.46) \0.001 1.34 (1.10–1.58) \0.001
Impairment category
0 Ref. Ref.
1–3 0.40 (0.34–0.46) \0.001 0.06 (-0.06 to 0.18) 0.305
4–6 0.54 (0.44–0.65) \0.001 0.44 (0.31–0.56) \0.001
7–10 0.75 (0.39–1.11) \0.001 0.73 (0.53–0.93) \0.001
Constant 3.53 (2.99–4.08) \0.001 6.90 (6.46–7.35) \0.001
Interactions
Gender 9 age v2 = 18.47, df = 4 \0.001 v2 = 6.23, df = 4 0.1826
Gender 9 MM v2 = 35.51, df = 3 \0.001 v2 = 1.12, df = 3 0.7727
Gender 9 MI v2 = 5.94, df = 3 0.1147 v2 = 7.96, df = 3 0.0469
Age 9 MM v2 = 76.19, df = 12 \0.001 v2 = 60.44, df = 12 \0.001
Age 9 MI v2 = 66.10, df = 12 \0.001 v2 = 30.46, df = 12 0.0024
YD 9 gender v2 = 9.35, df = 1 0.0022 v2 = 0.00, df = 1 0.9871
YD 9 age v2 = 630.85, df = 4 \0.001 v2 = 57.73, df = 4 \0.001
YD 9 MM v2 = 259.55, df = 3 \0.001 v2 = 28.71, df = 3 \0.001
YD 9 MI v2 = 66.28, df = 3 \0.001 v2 = 71.43, df = 3 \0.001
N. C. Hazra et al.
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decedents in the last 12 months of life were generally
inverse-squared terms, while cubic terms were selected for
analysis of costs among survivors.
Annual predicted costs of health care utilization
increased from age 80 to age 97 (men) or 98 (women)
(Fig. 2, left panel), before declining to age 105 years.
Estimated costs by single year of age are presented in
Supplementary Table 2. The effect of age differed for
decedents and survivors (Fig. 2, right panel). Costs incur-
red among decedents in the last 12 months of life declined
steeply with age, while among survivors costs tended to
remain constant with age apart from a slight decline at the
oldest ages. The data are presented disaggregated by sub-
group of comorbidity and age-related impairment in Fig. 3.
Among survivors, costs increased as the number of
comorbidities and impairments increased but showed no
consistent trend with age. Among decedents, costs
decreased with age with the steepest declines observed in
the highest categories of comorbidity or impairment. In the
last 12 months of life, costs also were higher as the number
of comorbidities increased in all age groups and were
greater as the number of impairments increased in octo-
genarians and nonagenarians, but not in centenarians. For
participants without comorbidity or impairment, age was
more weakly associated with costs incurred by decedents in
the last 12 months of life.
Discussion
Summary of findings
This study investigated associations between health care
costs and age, proximity to death, comorbidity, and
impairment among the senior elderly. The study presents
novel data concerning the main drivers of health care costs
in a large cohort of participants aged 80 years and older in
the UK. Previous studies evaluating health care costs in the
elderly evaluate younger elderly populations [5, 15, 33, 34]
and age-stratified results beyond 80 years have rarely been
presented but have unique features that deserve separate
attention. At the population level, mean costs of health care
utilization increased with age at least until the mid-nona-
genarian years before declining in centenarians. The latter
trend may result from a selection effect where the health-
iest individuals survive to the oldest ages [10]. When
controlling for proximity to death, comorbidity, and
Fig. 1 Proportion with different number of comorbidities and age-
related impairments by age
Table 4 Distribution of predicted costs of health care utilization by
participant characteristics and age group
80–84 85–89 90–94 95–99 100?
All participants 3095 3686 4081 4322 3698
Male 3295 4020 4600 4797 4030
Female 2882 3372 3721 4174 3625
Not last year 2579 2848 2948 2834 2004
Last year of life 10,027 9707 8677 7938 7021
Comorbidities [survivors]
0 598 807 758 535 103
1–3 1796 2107 2209 2277 1728
4–6 3084 3273 3385 3371 2799
7? 5026 4995 5413 4728 4706
Comorbidities [decedents]
0 3608 4856 4799 4123 2854
1–3 7123 7527 6966 6852 6380
4–6 11,200 10,576 9456 8798 7783
7? 14,308 12,752 11,848 9561 8950
Impairments [survivors]
0 1802 1872 1670 1291 638
1–3 2481 2704 2754 2615 1971
4–6 3856 3833 3764 3586 2868
7? 5225 4916 4994 4336 3206
Impairments [decedents]
0 8382 8012 6677 5930 8182
1–3 9650 9409 8487 7785 6994
4–6 11,808 10,734 9249 8381 6904
7? 14,500 12,273 11,002 9118 6752
Figures are UK £2014
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impairment, age was only weakly associated with costs,
consistent with the ‘red herring’ claim. In the subgroup of
participants who are in the last year of life, costs of health
care utilization were negatively associated with age, rather
than the almost universally expected positive association
that Zweifel et al. have disputed. Declining costs with age
among decedents was also reported in a primarily
descriptive study of aggregate level data from the US [21],
but represents a new finding in the UK. Among survivors,
comorbidities and age-related impairments, rather than age,
were associated with health care costs. The ‘red herring’
hypothesis, however, focuses on time to death rather than
comorbidities, recognizing that the share of people close to
death rises with age. This also applies to comorbidities and
impairments; health care costs are a function of health
status as the proportion with greater morbidity generally
increases with age before declining beyond the mid-90s.
Disentangling the independent effects of these character-
istics is complex, some of which may be viewed as
mediating variables. We argue that, when it comes to rising
health care costs as populations age, our attention must
start shifting towards subgroup-level characteristics of
Table 5 First- and second-order term for age from fractional polynomial models with predicted costs of health care utilization as dependent
variable, by participant characteristics
Group First term Second term
Men X3 - 657.2 (p\ 0.001) X3 9 ln(X) - 1421.4 (p\ 0.001)
Women X3 - 696.5 (p\ 0.001) X3 9 ln(X) - 1519.7 (p\ 0.001)
Surviving X3 - 669.4 (p\ 0.001) X3 9 ln(X) - 1451.8 (p\ 0.001)
Died in year X-2 - 0.0123 (p\ 0.001) X-2 9 ln(X) - 0.0270 (p\ 0.001)
Surviving Died Surviving Died
Number of morbidities
0 X-2 - 0.0126 (p\ 0.001) X-2 - 0.0120 (p\ 0.001) X-2 9 ln(X) - 0.0276 (p\ 0.001) X-2 9 ln(X) - 0.0266 (p\ 0.001)
1–3 X3 - 670.0 (p\ 0.001) X-2 - 0.0121 (p\ 0.001) X3 9 ln(X) - 1453.2 (p\ 0.001) X-2 9 ln(X) - 0.0267 (p\ 0.001)
4–6 X3 - 668.0 (p\ 0.001) X-2 - 0.0123 (p\ 0.001) X3 9 ln(X) - 1448.4 (p\ 0.001) X-2 9 ln(X) - 0.0271 (p\ 0.001)
C7 X3 - 660.3 (p\ 0.001) Age - 88.90 (p\ 0.001) X3 9 ln(X) - 1429.0 (p\ 0.001) –
Number of impairments
0 X-2 - 0.0133 (p\ 0.001) X3 - 706.8 (p\ 0.001) X-2 9 ln(X) - 0.0287 (p\ 0.001) X3 9 ln(X) - 1545.7 (p\ 0.001)
1–3 X3 - 662.6 (p\ 0.001) X-2 - 0.0124 (p\ 0.001) X3 9 ln(X) - 1434.8 (p\ 0.001) X-2 9 ln(X) - 0.0272 (p\ 0.001)
4–6 X3 - 698.9 (p\ 0.001) X0.5 - 3.0 (p\ 0.001) X3 9 ln(X) - 1525.7 (p\ 0.001) –
C7 X3 - 725.2 (p\ 0.001) Age - 91.6 (p\ 0.001) X3 9 ln(X) - 1592.2 (p\ 0.001) –
X refers to age/10
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health status, as evaluated in our study, rather than age
alone at a population level, particularly because time to
death is difficult to quantitatively ascertain or predict.
Comparison to existing literature
Population-based empirical studies concerning the complex
relationship between health care costs, age, and health
status are lacking in the senior elderly. Previous costing
studies in the elderly have evaluated associations with
health care costs and a variety of factors, but actual esti-
mated cost figures in over-80s are scarce in the literature.
Mean annual costs of health and social care have been
reported at £7704 among over-70s discharged from an
acute medical unit in England [8], a higher estimate than
our figures, which is likely due to the inclusion of social
care costs in the study and the severity of the sample’s
health status. Existing research in the US has also reported
average Medicare per-capita spending in 2011 more than
doubling from $7566 at age 70 to $16,145 at age 96 before
falling, with higher spending in mid-to-late 90s driven by
spending on skilled nursing facilities, hospice care, and
home health services [21]. When these services were
excluded, per-capita spending peaked at age 89. Consistent
with our data reporting males using more secondary care
and females accounting for more prescription costs, a
Canadian study described males aged 65 years and older
using more specialist care, emergency room visits, and
surgical admissions, with females using significantly more
medications and attending more GP visits [34].
Compared to younger elderly individuals aged 65–79,
octogenarians have also been reported to attend
significantly more GP visits (4.4 visits per person year) and
use more medications (8.2 per person year) [34], which is
supported by our results showing increasing rates of GP
visits with age from 80 to 90 years. Our study supplements
this with new data illustrating a decreasing rate of GP visits
beyond 90 years of age, with a concurrent increase in home
visits, out-of-hours and telephone consultations among
nonagenarians and centenarians. Modestly rising health
care costs from 80 years and declining costs beyond
95 years between 2010 and 2014 observed in our study
show consistent patterns with an older American study
reporting increases in any physician contact from 70 years
of age up to 85 years, followed by a lower probability of
any physician contact beyond 85 years between 1993 and
1995 [5]. The study, however, focused primarily on ethnic
and racial disparities in health care utilization, and our
study is the first using UK data to evaluate proximity to
death or the relationship between costs and other health-
related covariates compared to age.
The fixed percent breakdown of primary care, secondary
care, and prescription costs in our cohort across age groups
and type of condition represents a new finding among over-
80s and is relatively consistent with an English study
identifying patient-level health and social care costs among
over-70s reporting an 11% and 76% cost contribution from
primary and secondary care, respectively [8]. Franklin et al.
however, did not stratify by age group or include pre-
scription costs. The study included social care costs in
addition to health care costs, reporting a social care cost
contribution of 10% for all health and social care costs.
A review reporting health care costs having a curvilinear
positive, nearly exponential, relationship with multiple
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chronic conditions in younger elderly groups [14] is con-
sistent with our findings in the senior elderly illustrating a
positive relationship between level of comorbidity and
health care costs. However, our study is the first to report
data for over-80s on the relationship between costs and a
multitude of age-related impairments, including cognitive
impairment, falls, fractures, hearing impairments, and
dementia, showing increasing impairment and comorbidity
being an even greater driver of costs compared to age and
gender. It is established in the literature that the cost of
health and social care among individuals at the end of life
is significant, and much of this cost is borne by informal
care givers [27, 33]. Our analysis indicates that high costs
of care at the end of life also holds true in a health care
setting alone and we provide new evidence regarding the
differing effect of age, comorbidity, and impairment on
costs among decedents in the last 12 months of life com-
pared to survivors in an English dataset.
Strengths and limitations
This study’s findings are strengthened by its use of a large
nationally representative sample of senior elderly, enabling
us to analyze longitudinal utilization data for up to 7% of
the UK population. Use of primary care EHRs facilitated
analysis by age group for a wide range of chronic condi-
tions and impairments in a large sample. Approximately
98% of the UK population will be registered with a family
practice, ensuring our results are population based.
However, several limitations to our study must be
acknowledged. We did not have access to data on partici-
pants’ place of residence and therefore could not charac-
terize individuals based on whether they lived in a
residential care home or in a private residence. Analysis
from our previous study on centenarians revealed difficul-
ties in ascertaining place of residence in CPRD [10]. Par-
ticipants could be moving into residential care homes, which
may affect recording of utilization patterns in CPRD by
potentially underestimating health care costs for this popu-
lation. Institutionalization has been shown in the literature to
make up a large part of health care costs for the elderly [15],
with most spending among high-cost users coming from
institutional care [37], but we did not have access to social
care data outside CPRD. The present analysis might
underestimate total end of life costs for care from a societal
perspective but still accurately captures the effects on the
health care system itself. An understanding of social care
utilization would be a particularly valuable addition to this
analysis, in order to provide a complete picture of all health
and social care costs among the senior elderly and how they
are borne by each sector. Further research might also
examine the relationship between type of disease, proximity
to death, and age, as in Wong et al. [38].
Our study still provides important new figures from a
comprehensive health care perspective on the complex
relationship between health care costs and its potential
determinants, in a severely understudied and rapidly
growing group of senior elderly in the UK. We most
importantly report new findings on the polarized associa-
tion between age and health care costs by proximity to
death.
Our calculation of hospital inpatient episodes in HES
represents an inpatient consultation in the care of one
consultant. This may be recorded as two episodes even if
the patient is in the hospital for one problem. For example,
hip replacement may be recorded as an orthopedic episode
and a geriatric episode. This may slightly overestimate our
calculations for inpatient hospital consultations. It should
be noted that prescriptions recorded in CPRD likely reflect
mostly primary care prescriptions as prescriptions given in
the hospital are generally for a short duration. However,
these hospital prescriptions are likely to be bundled into the
consultation cost through the NHS tariffs and any new
ongoing prescriptions started in the hospital would be
continued by primary care prescribers. Therefore, our data
picks up these prescription costs through an initial brief
upfront cost in the hospital.
We performed additional robustness checks considering
other potential model specifications. The possibility of
using a finite mixture of GLMs was considered, used pre-
viously by Eckardt et al., but was not adopted due to little
improvement in reported goodness-of-fit [7]. In addition,
we were interested in the relative and independent effects
of comorbidity and impairment category, proximity to
death and age on health care costs rather than under-
standing identifiable components of various comorbidity
groups. Using a negative binomial regression was also
explored, but was deemed not appropriate for our data due
to its suitability for over-dispersed count data.
Conclusions
The findings of this study indicate that impairment and
comorbidity are stronger drivers of health care costs than
increased age alone, with proximity to death being the
strongest predictor of high costs. The importance of prox-
imity to death is highlighted in our findings through the
contrasting relationship between age and cost contingent
on proximity to death. While our population-level analysis
supports the ‘red herring’ hypothesis, we also present
declining costs with age among decedents in the last
12 months of life, demonstrating an unconventionally
negative age gradient at this subgroup level. We also
highlight the need for a shift from a population-based
emphasis on age towards a more stratified subgroup-level
approach that further recognizes health status when
N. C. Hazra et al.
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evaluating health care costs in over-80s. These new find-
ings will be essential in helping inform policy-makers
responsible for priority setting and planning for the health
care needs of an ageing population. More research is
required to further understand the components of health
care costs in the months before death, with the incorpora-
tion of social care and institutional costs. Public health
efforts will be crucial in reducing high levels of age-related
impairments and chronic morbidities, and their associated
costs, in addition to better managing these conditions in the
senior elderly.
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